At Singleron Biotechnologies, we are excited to announce the launch of the first commercially available technology that can detect glycosylation together with the whole transcriptome at a single cell level; ProMoSCOPE
.
Post-translational modification of proteins, such as glycosylation, can directly regulate cellular functions and play important roles in diseases and immunity. It remains to be understood whether and how such post-translational modifications and gene expression patterns are related to each other at a single-cell level in complex biological systems. Singleron‘s innovative technology ProMoSCOPE enables researchers to get new insights by combining whole transcriptomics and glycosylation detection at the single-cell level. ProMoSCOPE data analysis pipeline is now freely available on GitHub.
Join our webinar and learn about:
- Importance of glycosylation detection across various research fields
- Our new chemoenzymatic method to quantify cell surface glycosylation at single cell level
- What the quantitative multimodal information can reveal about diseases and immunity
Wednesday, November 29, 2022 at 10 AM (CET)
Our speaker:
Dr. Murat Seker
Product Manager @Singleron Biotechnologies GmbH
Murat Seker received his MSc in Life Science at National Taiwan University, Taiwan and his Ph.D. in Molecular Biology from Humboldt University, Germany in 2022 for his work elucidating magnesium regulation in the kidney. In February 2022, Murat joined Singleron Biotechnologies, where he oversees single-cell multi-omics products portfolio and single-cell sequencing service as a Product Manager.
